what to do if your body doesn't process glutathione dysregulation and the etiology and progression of human diseases Glutathione: Pharmacological aspects and implications
Description
doi: 10.1186/s13073-016-0303-2 28 BretonJ.TennouneN.LucasN.FrancoisM.LegrandR.JacquemotJ.et al
additional markers such as MMA or homocysteine may be considered if borderline deficiency is suspected
In conclusion, the findings of this study indicate that all examined biomarkersinterleukin-6 (IL-6), C-reactive protein (CRP), and tumor necrosis factor-alpha (TNF-)may serve as valuable prognostic indicators for potential complications associated with diabetes
doi:10.1096/fj.08-125435
doi: 10.3390/biom14091166
Emerging promise of sulforaphane-mediated Nrf2 signaling cascade against neurological disorders
